ClinicalTrials.Veeva

Menu

Communication Bridge Pilot Study (CB3_1)

The University of Chicago logo

The University of Chicago

Status

Active, not recruiting

Conditions

Primary Progressive Aphasia

Treatments

Behavioral: Communication Bridge

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06211374
IRB23-1620
7R01AG055425-07 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The aim of this study is to evaluate the effectiveness and feasibility of evidence-based interventions in individuals living with mild to moderate primary progressive aphasia (PPA) that address communication-focused outcomes.

Full description

The purpose of this study is to evaluate the effectiveness and feasibility of evidence-based interventions in individuals living with mild to moderate primary progressive aphasia (PPA) that address communication-focused outcomes. The study team aims to enhance the personal relevance and therapeutic impact of goal attainment scaling (GAS) while building self-efficacy within a self-management framework.

This study will be a continuation of one of the largest non-pharmacologic intervention studies for individuals with PPA to date. It will add critical information regarding the effectiveness of telepractice interventions for communication disorders in adults with primary progressive aphasia specifically, and in dementia more broadly. The goal of this study is to maximize functional communication and life participation for the participants.

Enrollment

12 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (person with PPA):

  1. Meets diagnostic criteria for PPA based on neurologist and supporting medical assessments (extracted from medical records)
  2. English as primary language used in daily communication activities (by self-report)
  3. Adequate hearing (aided or unaided) for communicating with others in a crowded room (by self-report)
  4. Adequate vision (aided or unaided) for reading a newspaper, or other functional materials (by self-report)
  5. Able to pass technology screening and demonstrates sufficient knowledge for use of video conference and Communication Bridge™ web application use (with or without training)
  6. Geriatric Depression Scale score ≤ 9
  7. Mild-moderate PPA informed by a structured interview with a speech-language pathologist and a standardized testing battery.

Inclusion Criteria (Co-enrolled communication partner):

  1. 18+ years of age
  2. English as primary language used in daily communication activities (by self-report)
  3. Adequate hearing (aided or unaided) for communicating with others in a crowded room (by self-report)
  4. Able to pass technology screening* and demonstrates sufficient knowledge for use of video conference and Communication Bridge™ web application use (with or without training)

Exclusion Criteria:

  • A dementia diagnosis other than Primary Progressive Aphasia
  • Participation is co-enrolled in an outside speech language therapy program during the study course.
  • Communication partners will be excluded if they have a pre-existing communication impairment that would affect study participation (e.g., aphasia, dementia) Medical records will be requested and reviewed to determine eligibility

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

Communication Bridge™
Experimental group
Description:
Participants receive Communication Bridge™, a multi-component, participation-focused, dyadic intervention in which both the person with PPA and their co-enrolled communication partner are intervention recipients. Communication Bridge™ is modelled on the Living with Aphasia: Framework for Outcome Measurement (A-FROM) and the Care Pathway Model that was developed for persons living with primary progressive aphasia. Consistent with participation-focused intervention models personally salient training stimuli are incorporated into all therapy activities in the Experimental arm.
Treatment:
Behavioral: Communication Bridge

Trial contacts and locations

1

Loading...

Central trial contact

Emily Cummings; Matthew Bona, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems